Combined and Simultaneously Administered Vaccines

[1]  C. Dekker,et al.  Protective efficacy of the Takeda acellular pertussis vaccine combined with diphtheria and tetanus toxoids following household exposure of Japanese children. , 1990, American journal of diseases of children.

[2]  E. Larson.  Food and Drug Administration Approval of Use of Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine , 1992, Infection Control & Hospital Epidemiology.

[3]  M. Levine,et al.  The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age. , 1991, The Pediatric infectious disease journal.

[4]  B. Yvonnet,et al.  Simultaneous administration of diphtheria-tetanus-pertussis-polio and hepatitis B vaccines in a simplified immunization program: immune response to diphtheria toxoid, tetanus toxoid, pertussis, and hepatitis B surface antigen , 1986, Infection and immunity.

[5]  Violaine S. Mitchell,et al.  The children's vaccine initiative : achieving the vision , 1993 .

[6]  B. Fritzell,et al.  Study of combined vaccination against yellow fever and measles in infants from six to nine months. , 1989, Journal of Biological Standardization.

[7]  M. Levine,et al.  Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine does not depress serologic responses to diphtheria, tetanus or pertussis antigens when coadministered in the same syringe with diphtheria-tetanus-pertussis vaccine at two, four and six months of age. , 1993, The Pediatric infectious disease journal.

[8]  A. Schaafsma,et al.  Combined immunization against poliomyelitis, diphtheria, whooping cough, tetanus and smallpox. , 1963, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[9]  B. Yvonnet,et al.  SIMULTANEOUS ADMINISTRATION OF HEPATITIS B AND DIPHTHERIA/TETANUS/POLIO VACCINES , 1984, The Lancet.

[10]  H. T. Lin,et al.  A study of the effect of simultaneous vaccination with BCG and smallpox vaccine in newborn infants. , 1966, Bulletin of the World Health Organization.

[11]  A. T. Glenny,et al.  Diphtheria Toxoid as an Immunising Agent. , 1923 .

[12]  A. Wardlaw,et al.  Aluminium compounds as adjuvants for vaccines and toxoids in man: a review. , 1966, Canadian journal of public health = Revue canadienne de sante publique.

[13]  S. Lerman,et al.  Clinical and serologic evaluation of measles, mumps, and rubella (HPV-77:DE-5 and RA 27/3) virus vaccines, singly and in combination. , 1981, Pediatrics.

[14]  J. Eskola,et al.  Simultaneous administration of Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine with routine diphtheria-tetanus-pertussis and inactivated poliovirus vaccinations of childhood. , 1988, The Pediatric infectious disease journal.

[15]  Aprile Ma,et al.  Aluminium compounds as adjuvants for vaccines and toxoids in man: a review. , 1966 .

[16]  S. Musumeci,et al.  Immune response to simultaneous administration of a recombinant DNA hepatitis B vaccine and multiple compulsory vaccines in infancy. , 1991, Vaccine.

[17]  B. Yvonnet,et al.  Simultaneous injection of hepatitis B vaccine with BCG and killed poliovirus vaccine. , 1992, Vaccine.

[18]  K. Yamanishi,et al.  Studies on live rubella vaccine. V. Quantitative aspects of interference between rubella, measles and mumps viruses in their trivalent vaccine. , 1974, Biken journal.

[19]  K. Gyr,et al.  Simultaneous vaccination against cholera and yellow fever. , 1973, Lancet.

[20]  K. Bart,et al.  Vaccine-preventable disease and immunization in the developing world. , 1990, Pediatric clinics of North America.

[21]  M. Hilleman,et al.  Combined live measles, mumps, and rubella virus vaccines. , 1969, JAMA.

[22]  P. Meers.  Further observations on 17D-yellow fever vaccination by scarification, with and without simultaneous smallpox vaccination. , 1960, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[23]  E. Vittinghoff,et al.  Safety and immunogenicity of oligosaccharide conjugate Haemophilus influenzae type b (HbOC) vaccine in infancy. The Northern California Kaiser Permanente Vaccine Study Center Pediatrics Group. , 1991, The Pediatric infectious disease journal.

[24]  R. Dagan,et al.  Safety and immunogenicity of Haemophilus type b-tetanus protein conjugate vaccine, mixed in the same syringe with diphtheria-tetanus-pertussis vaccine in young infants. , 1991, The Pediatric infectious disease journal.

[25]  E. Wald,et al.  Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants. , 1990, Pediatrics.

[26]  M. Peltier.  Yellow fever vaccination, simple or associated with vaccination against smallpox, of the populations of French West Africa by the method of the Pasteur Institute of Dakar. , 1947, American journal of public health and the nation's health.

[27]  E. Rothstein,et al.  Simultaneous administration of measles-mumps-rubella vaccine with booster doses of diphtheria-tetanus-pertussis and poliovirus vaccines. , 1988, Pediatrics.

[28]  M. Levine,et al.  Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine. , 1992, JAMA.

[29]  Food and Drug Administration approval of a second diphtheria and tetanus toxoids and acellular pertussis vaccine. , 1992, MMWR. Morbidity and mortality weekly report.